Breakthrough Chemistry, Inc. (BKTH)
0.085
-0.01
(-13.97%)
USD |
OTCM |
Nov 20, 16:00
Breakthrough Chemistry Enterprise Value : 0.8565M for Nov. 20, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 20, 2026 | 0.8565M |
| November 19, 2026 | 1.000M |
| November 18, 2026 | 0.8609M |
| November 17, 2026 | 0.6182M |
| November 16, 2026 | 0.7418M |
| November 13, 2026 | 0.7418M |
| November 12, 2026 | 0.747M |
| November 11, 2026 | 0.747M |
| November 10, 2026 | 0.747M |
| November 09, 2026 | 0.747M |
| November 06, 2026 | 0.7783M |
| November 05, 2026 | 0.88M |
| November 04, 2026 | 0.88M |
| November 03, 2026 | 0.8758M |
| November 02, 2026 | 0.7573M |
| October 30, 2026 | 0.8878M |
| October 29, 2026 | 0.8878M |
| October 28, 2026 | 1.002M |
| October 27, 2026 | 0.9087M |
| October 26, 2026 | 0.9087M |
| October 23, 2026 | 0.9608M |
| October 22, 2026 | 1.013M |
| October 21, 2026 | 0.7105M |
| October 20, 2026 | 1.013M |
| October 19, 2026 | 1.013M |
| Date | Value |
|---|---|
| October 16, 2026 | 1.251M |
| October 15, 2026 | 1.251M |
| October 14, 2026 | 0.9087M |
| October 13, 2026 | 0.9087M |
| October 12, 2026 | 0.7105M |
| October 09, 2026 | 0.9608M |
| October 08, 2026 | 0.9608M |
| October 07, 2026 | 1.086M |
| October 06, 2026 | 1.085M |
| October 05, 2026 | 1.085M |
| October 02, 2026 | 1.085M |
| October 01, 2026 | 1.036M |
| September 30, 2026 | 1.508M |
| September 29, 2026 | 0.241M |
| September 28, 2026 | 0.2897M |
| September 25, 2026 | 0.2897M |
| September 24, 2026 | 0.2381M |
| September 23, 2026 | 0.2381M |
| September 22, 2026 | 0.2381M |
| September 21, 2026 | 0.2381M |
| September 18, 2026 | 0.0542M |
| September 17, 2026 | 1.214M |
| September 16, 2026 | 0.6886M |
| September 15, 2026 | 1.506M |
| September 14, 2026 | 1.506M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Cardiac Biotech Solutions, Inc. | 6.415M |
| Precision Optics Corp., Inc. | 40.16M |
| Petros Pharmaceuticals, Inc. | -3.400M |
| RxSight, Inc. | -56.95M |
| Vyome Holdings, Inc. | 3.037M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -0.7984M |
| Revenue (Quarterly) | 0.0025M |
| Total Expenses (Quarterly) | 0.8009M |
| EPS Diluted (Quarterly) | -0.0816 |
| Profit Margin (Quarterly) | -31.94K% |
| Earnings Yield | -213.3% |
| Normalized Earnings Yield | -127.06 |